A registry is an organized system that uses
observational study methods to collect uniform
data to evaluate specific outcomes, to establish
databases, to conduct further study and to improve
quality. ICU data registry is recording
information about patients during admission,
health care they receive their prognosis and
outcome during ICU stay. This allows health care
professionals to see what treatment is available,
and how patients with different characteristics
respond to various treatments. This information
can be used to improve quality care for patients
in the future. Intensive care registries have been
considered to play an important role in measuring
and evaluating the outcomes of patient treatment
and categorizing standards of services.
REMAP-CAP
REMAP-CAP is a randomized, embedded,
multifactorial, adaptive platform trial for
community-acquired pneumonia. The purpose of this
study is to evaluate the effect of a range of
interventions to improve outcome of patients
admitted to intensive care with community-acquired
pneumonia. In addition, REMAP-CAP provides and
adaptive research platform for evaluation of
multiple treatment modalities in the event of a
respiratory pandemic such as COVID-19. REMAP-COVID
is a sub-platform of REMAP-CAP that evaluates
treatments specific to COVID-19.
REMAP-CAP sites in Nepal :
1
HAMS Hospital
2
Grande International Hospital
3
Chitwan Medical College
4
Nepal Mediciti
4
Tribhuvan University Teaching Hospital
(TUTH)
Clinical Trial: The Mega Randomized Registry Trial
comparing Conservative vs Liberal Oxygenation
Targets (MegaRox)
MegaRox
Mega-ROX is a series of multicentre,
multinational, randomized, parallel-group,
registry-embedded clinical trials nested within an
overall 40,000-patient trial sample.
MEGA-ROX sites in Nepal :
